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We  present  a  case  of congenital  lymphedema  in a  7-year-old  boy  in Sierra  Leone with active  ﬁlarial
infection  and  penile  edema.  The  genital  edema  with  onset  at 6 months  of age  may  have  been  due  to  a
congenital  abnormality  in  lymphatic  drainage.  Other  possible  causes  of  childhood  lymphedema,  including
Milroy’s  disease,  are  discussed.
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. Introduction
Lymphatic ﬁlariasis (LF) is a major cause of acute and chronic
orbidity manifested as lymphedema and hydrocele. The clinical
igns and symptoms of LF affect more than 40 million people glob-
lly, making the disease the second-largest cause of permanent and
ong-term disability worldwide (Shenoy and Bockarie, 2011; Chu
t al., 2010). LF is a major obstacle to socioeconomic development in
he 73 countries across Africa, Southeast Asia, the Americas, and the
aciﬁc region that are known to be endemic for the mosquito-borne
isease (WHO, 2013; Addiss, 2010).
LF infection is often acquired in childhood in areas of high trans-
ission intensity, but infected individuals usually do not develop
linical disease until years later when they are adults. More than
50 million children are exposed to LF worldwide, and in high
∗ Corresponding author at: Mercy Hospital Research Laboratory, Kulanda Town,
o,  Sierra Leone. Tel.: +232 76 683832.
E-mail address: r.ansumana@liverpool.ac.uk (R. Ansumana).
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ttp://dx.doi.org/10.1016/j.actatropica.2014.02.007
001-706X/© 2014 The Authors. Published by Elsevier B.V. This is an open access article unendemic areas up to 10% of children under the age of 15 years are
infected (Bockarie et al., 2002). In 2000, the World Health Organiza-
tion launched the Global Program to Eliminate LF (GPELF) using the
pro-poor strategy of preventive chemotherapy and transmission
control (PCT) together with vector control, morbidity management,
and disability prevention (WHO, 2013). The mass drug administra-
tion (MDA) strategy used for PCT combines albendazole with either
ivermectin or diethylcarbamazine citrate (DEC). However, not all
at-risk children in high-risk areas are able to access MDA.
Lymphatic ﬁlariasis caused by Wuchereria bancrofti is highly
endemic in Sierra Leone, where more than 90% of the 6.6 million
people are at risk of acquiring the infection. (Hodges et al., 2012;
Koroma et al., 2012) Filarial disease is common in all the endemic
districts in the country, but there is no record previously of
lymphedema in a child less than 10 years old. Here we present a
case of lymphedema in a 7-year-old boy with patent LF.2. Case report
During a transmission assessment survey to determine the suc-
cess of four rounds of MDA  on reducing LF transmission in north
der the CC BY-NC-SA license (http://creativecommons.org/licenses/by-nc-sa/3.0/).
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weighed the potential risks. Additionally, the ballooning foreskinFig. 1. Lymphedema of Right Lower Extremity.
entral Pujehun District, Sierra Leone, a 7-year-old boy from a
ural village presented with chronic progressive lymphedema of
he right lower extremity. The overlying tissue of the distal extrem-
ty was indurated, possibly due to secondary infection and tissue
rauma, and there were dermatologic changes of the right foot con-
istent with elephantiasis (Fig. 1). The temperature of the swollen
reas was normal, with no signs of nodular or warty excrescences.
he boy’s father reported that asymmetrical non-pitting edema had
een present since birth, and had increased in severity over time.
eratosis spots were present over the entire body, and the pre-
uce of the penis showed a signiﬁcant deformity that the father
aid had been present since the child was six months of age (Fig. 2).
he father gave permission for photographs of the child and case
nformation to be published.
The boy tested positive for circulating ﬁlarial antigenemia using
 BinaxNOW ﬁlariasis Immuno Chromatographic Test (ICT) (Inver-
ess Medical Professional Diagnostics, Preehold, NJ, USA), and a
ight blood smear examination with Giemsa stain conﬁrmed Ban-
roftian ﬁlariasis with 313 W.  bancrofti mf/ml  of blood prior to
reatment. The parasite was sheathed with nuclei in the tail end and
as morphologically distinguishable from the Mansonella species
hich can also be found in human blood in Africa. These observa-
ions and the species-speciﬁc ICT positive result conﬁrmed that the
icroﬁlaria observed in the blood were W.  bancrofti. Initial treat-
ent prescribed for the active ﬁlarial infection was a 6 mg  dose of
vermectin and a 400 mg  dose of albendazole every three months
ith follow-up. The father reported that the boy had not been pre-
iously treated for LF infection.
The boy had lived with his parents in rural Pujehun District for
he past four years, and they previously resided in Kono District
Fig. 3). Before her pregnancy with the boy and during the end of
er ﬁrst trimester, his mother had resided in Kono District with her
randmother, a resident of Bombali District, who had elephantiasis.Fig. 2. Deformed Prepuce.
Both Bombali and Kono Districts were endemic for LF prior to the
MDA and the birth of the boy (Koroma et al., 2013).
As part of the investigation of the child’s disease, family mem-
bers were examined for LF. The mother tested LF positive based
on both ICT and night blood smear examination, and reported tak-
ing only one round of MDA  during her lifetime. The boy’s father
and the boy’s only sibling both tested negative. None of the imme-
diate family members had anatomical abnormalities related to LF.
However, a family history suggested that the boy’s deceased mater-
nal grandmother likely also had an advanced ﬁlarial infection, as
she had progressive lymphedema of the lower right extremity that
developed over the last ﬁve years of her life.
Two months after the boy’s initial diagnosis, following pre-
scribed treatment with ivermectin and albendazole, a night blood
smear test showed no evidence of circulating microﬁlaria. A com-
plete blood count, comprehensive metabolic panel, and urinalysis
were all found to be within normal limits. A physical examination
revealed no evidence of another inciting condition. Both the child
and his father were also tested at this time for several other infec-
tious diseases, including human immunodeﬁciency virus (HIV),
dengue, leptospirosis, chikungunya, malaria, syphilis, onchocerci-
asis, and hepatitis A, B, and C. Both tested positive for malaria, with
all other tests negative.
The patient was  prescribed a daily dose of 200 mg of doxy-
cycline, which has been shown to cause signiﬁcant reductions
in lymphedema in patients with Grade II–III LF following 12–24
months of treatment, regardless of circulating ﬁlarial status (Mand
et al., 2012). Although some risk of adverse effects has been
reported in administration of doxycycline to children under 10
years old, the treating physician concluded that with appropriate
safety monitoring the beneﬁts of doxycycline for this patient out-of the boy was removed through circumcision. The biopsied tissue
was unremarkable.
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. Discussion
Lymphatic ﬁlariasis is rarely symptomatic in children, espe-
ially those who are less than 10 years old, and when children do
ave symptoms LF rarely presents as lymphedema (Bockarie et al.,
009). A comprehensive meta-analysis of LF in children by Witt and
ttesen (2001) identiﬁed only 5 cases of lymphedema or elephan-
iasis of a limb in children less than 10 years old in the published
iterature, most of which occurred in the mid-20th century. A study
rom the mid-1990s of 441 Indian children (ages 1–14 years) with
F found only 12 cases of lymphedema (Harinath et al., 2000). Thus,
he case patient appears to have an unusual presentation of lower
imb enlargement in a 7-year old boy infected with W.  bancrofti.
One possible cause of this congenital deformity is Milroy’s dis-
ase, an autosomal dominant genetic disorder characterized by
ymphedema, especially lymphedema of the legs, that is present
t birth or develops in infancy (Makhoul et al., 2002). A 2011 case
eport from an LF non-endemic area described a healthy full-term
ewborn with no complications during pregnancy or delivery who
eveloped swelling of his right leg soon after birth (Perez-Crespo
t al., 2011). As observed in our case, the lower limb swelling
as more pronounced in the distal part of the leg and foot. The
kin showed non-pitting edema and no swelling signs in the area.
he family history was also similar to ours. The grandmother and
ome maternal relatives were also found to be affected with lym-
hedema, including the child’s grandmother. Based on the family
istory and clinical examination alone, the patient was diagnosed
ith Milroy’s disease. Similar cases described elsewhere were
lso clinically diagnosed as Milroy’s disease (Connell et al., 2008;
itsiou-Tzeli et al., 2010). Milroy’s disease had also been associ-
ted with swelling of the genitals, as per a case report from Gueglio
t al. (2003) of giant scrotal lymphedema due to Milroy’s disease.
o relative of the 7-year old boy was known to have been born with of Case Patient and Familial Relations.
lymphedema, but up to 10% of persons with Milroy’s disease may be
asymptomatic (Brice et al., 2005). Advanced molecular diagnostics
would be required to conﬁrm that the lymphedema in the 7-year
old observed in Sierra Leone was  due to Milroy’s disease.
This study suggests that lymphedema due to LF in children may
be difﬁcult to diagnose because of the rarity of symptomatic LF
in the pediatric population. In LF-endemic areas, the possibility of
other causes of lymphedema in infected children should be care-
fully considered and Milroy’s disease should not be prematurely
excluded as a possible diagnosis.
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